WGRX - NASDAQ
Wellgistics Health, Inc.
$0.72
-7.8%Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
At a Glance
Live Snapshotwgrx
Total Current Liabilities
Last Annual Value
38.05M
3-Year CAGR
1835%
5-Year CAGR
492%
10-Year CAGR
143%
Wellgistics Health, Inc. Competitors Analysis of Total Current Liabilities
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Wellgistics Health, Inc. NASDAQ:WGRX | 38.05M | 136.2% | N/A | N/A | |
 Q32 Bio Inc. NASDAQ:QTTB | 11.35M | -7.0% | -8.0% | 5.9% | |
 PDS Biotechnology Corporation NASDAQ:PDSB | 9.48M | -11.4% | 20.3% | 3.6% |
Wellgistics Health, Inc. Fair Value Envelope
Related Guides
Continue your WGRX research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.